COVID-19 Announcement - ARC Capital

COVID-19 Announcement – ARC Capital

We want to express our support to all those affected by the coronavirus. During this major outbreak, ARC CAPITAL will continue working to provide help to all our clients and the entire international community with the following actions:

Maintain existing team members & wages, provide uninterrupted global telecommuting services

Actively participating in sending masks and tests from Asia to the affected areas

Help our clients to invest in companies directly related to the cure and prevention of COVID-19

Donating masks to affected areas in Europe

Our social commitment does not allow us to remain indifferent to this pandemic and we hope that it will be resolved soon.

ARC Capital Team

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission